Guoli Yang
Alzheimer's disease, a progressive neurodegenerative disorder, poses a significant challenge to healthcare systems worldwide. With an aging population, the prevalence of Alzheimer's disease is on the rise, making it a growing public health concern. Precision medicine, an emerging approach in healthcare, aims to tailor medical care to individual characteristics, including genetic makeup. Genetic testing has played a pivotal role in the evolution of precision medicine for Alzheimer's disease patients. In this article, we will explore the history and evolution of genetic testing in the context of Alzheimer's disease, its current applications, challenges, and the promise it holds for personalized treatment and prevention. Alzheimer's disease is characterized by the progressive decline of cognitive function, including memory, thinking, and reasoning. It is the most common cause of dementia in older adults. The disease is complex, with both genetic and environmental factors contributing to its development.
Teile diesen Artikel
English 
Spanish 
Chinese 
Russian 
French 
Japanese 
Portuguese 
Hindi 